Department of Cardiology and Internal Medicine, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
Internal Medicine, Critical Care, Sleep Medicine and Physiology, Cardiovascular Medicine, UC San Diego, PulmonaryLa Jolla, CA, 92037, USA.
Sleep Breath. 2023 Aug;27(4):1269-1277. doi: 10.1007/s11325-022-02704-0. Epub 2022 Sep 29.
Cardiac rehabilitation (CR) improves clinical outcomes in patients with cardiovascular disease (CDV). Patients with CVD often have multiple comorbidities, including obstructive sleep apnea (OSA), potentially affecting their ability to participate and achieve functional improvement during CR. We aimed to test the hypothesis that OSA reduces peak exercise capacity (EC) in patients undergoing CR and to explore if OSA treatment modifies this relationship.
Data from a retrospective cohort of CR patients was analyzed. OSA was defined as a respiratory event index > 5/h or physician diagnosis. Patients with OSA were considered "treated" if using continuous positive airway pressure regularly during the CR period. Change in METs was the primary study outcome.
Among 312 CR patients, median age of 67 years, 103 (33%) had known OSA (30 treated, 73 untreated). Patients with OSA vs. those with no OSA were more likely to be obese and male; otherwise, groups were similar. Compared with the no OSA group, patients with OSA had lower pre-CR METs (3.3 [2.9-4.5] vs. 3.9 [3.1-5], P = .01) and lower post-CR METs (5.3 [4-7] vs. 6 [4.6-7.6], P = .04), but achieved a similar increase in METs post-CR (1.8 [0.6-2.6] vs. 2.0 [0.9-3], P = .22). Furthermore, compared to no OSA, pre-CR and post-CR METs tended to be similar in patients with treated OSA, but lower in untreated patients, with similar increases in METs across all groups, even when adjusting for covariates via multivariable regression.
OSA is prevalent in patients with CVD undergoing CR. CR substantially improves exercise capacity independent of OSA status, but screening for-and treatment of-OSA may improve the absolute exercise capacity achieved through CR.
心脏康复(CR)可改善心血管疾病(CDV)患者的临床结局。患有 CVD 的患者通常有多种合并症,包括阻塞性睡眠呼吸暂停(OSA),这可能会影响他们在 CR 期间参与并实现功能改善的能力。我们旨在检验假设,即 OSA 会降低接受 CR 的患者的峰值运动能力(EC),并探讨 OSA 治疗是否会改变这种关系。
对 CR 患者回顾性队列研究的数据进行分析。OSA 的定义为呼吸事件指数>5/h 或医生诊断。如果在 CR 期间经常使用持续气道正压通气(CPAP),则认为 OSA 患者“接受了治疗”。METs 的变化是主要的研究结果。
在 312 名 CR 患者中,中位年龄为 67 岁,103 名(33%)患有已知的 OSA(30 名接受治疗,73 名未接受治疗)。与无 OSA 组相比,有 OSA 的患者更有可能肥胖和男性;否则,两组相似。与无 OSA 组相比,有 OSA 的患者在 CR 前的 METs 较低(3.3 [2.9-4.5] 比 3.9 [3.1-5],P=0.01),CR 后的 METs 也较低(5.3 [4-7] 比 6 [4.6-7.6],P=0.04),但 CR 后 METs 的增加相似(1.8 [0.6-2.6] 比 2.0 [0.9-3],P=0.22)。此外,与无 OSA 组相比,接受治疗的 OSA 患者的 CR 前和 CR 后 METs 趋于相似,但未接受治疗的患者的 METs 较低,所有组的 METs 增加相似,即使通过多变量回归调整了协变量。
CR 患者中 OSA 很常见。CR 可显著改善运动能力,与 OSA 状态无关,但筛查和治疗 OSA 可能会提高通过 CR 实现的绝对运动能力。